biocancell.com

Home - BioCanCell

Gene Therapy for Bladder Cancer. BC-819: Unique Technology, Potent Mechanism. Bladder Cancer: New Solutions Needed. Clinical Features of Bladder Cancer. Clinical Data: A Linear Path to Approval Based on FDA Guidance. BC-821: Next-Generation Recombinant Plasmid. Gene Therapy for Bladder Cancer. BC-819: Unique Technology, Potent Mechanism. Bladder Cancer: New Solutions Needed. Clinical Features of Bladder Cancer. Clinical Data: A Linear Path to Approval Based on FDA Guidance. 2014 Built by BioMarketing.

http://www.biocancell.com/

OVERVIEW OF biocancell.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

11

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR BIOCANCELL.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.0 out of 5 with 14 reviews

5 star

6

4 star

6

3 star

0

2 star

0

1 star

2

Hey there! Start your review of biocancell.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

3.3 seconds

FAVICON PREVIEW

16x16
32x32

CONTACTS AT BIOCANCELL.COM

BIOCANCELL THERAPEUTICS, INC.

AVRAHAM HAMPEL

8 HA●●●●M ST

JER●●●LEM , 97775

IL

972.●●●●6555

972.●●●●6550

IN●●@BIOCANCELL.COM

View this contact

BIOCANCELL THERAPEUTICS, INC.

AVRAHAM HAMPEL

8 HA●●●●M ST

JER●●●LEM , 97775

IL

972.●●●●6555

972.●●●●6550

IN●●@BIOCANCELL.COM

View this contact

BIOCANCELL THERAPEUTICS, INC.

AVRAHAM HAMPEL

8 HA●●●●M ST

JER●●●LEM , 97775

IL

972.●●●●6555

972.●●●●6550

IN●●@BIOCANCELL.COM

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2005 February 02
UPDATED: 2014 February 20
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

19

YEARS
3

MONTHS
16

DAYS

NAME SERVERS

1: dns1.name-services.com
2: dns2.name-services.com
3: dns3.name-services.com
4: dns4.name-services.com
5: dns5.name-services.com

REGISTRAR

ENOM, INC.

WHOIS : whois.enom.com

REFERRED : http://www.enom.com

CONTENT

PAGES IN
THIS WEBSITE

11

SSL

EXTERNAL LINKS

12

SITE IP

192.185.50.181

LOAD TIME

3.283 sec

SCORE

6.2

PAGE TITLE

Home - BioCanCell | biocancell.com Reviews

<META> DESCRIPTION

Gene Therapy for Bladder Cancer. BC-819: Unique Technology, Potent Mechanism. Bladder Cancer: New Solutions Needed. Clinical Features of Bladder Cancer. Clinical Data: A Linear Path to Approval Based on FDA Guidance. BC-821: Next-Generation Recombinant Plasmid. Gene Therapy for Bladder Cancer. BC-819: Unique Technology, Potent Mechanism. Bladder Cancer: New Solutions Needed. Clinical Features of Bladder Cancer. Clinical Data: A Linear Path to Approval Based on FDA Guidance. 2014 Built by BioMarketing.

<META> KEYWORDS

1 info@biocancell com

2 about us

3 the company

4 leadership

5 board of directors

6 technology

7 clinical program

8 development plan

9 pipeline

10 investors

CONTENT

Page content here

KEYWORDS ON PAGE

info@biocancell com,about us,the company,leadership,board of directors,technology,clinical program,development plan,pipeline,investors,corporate presentation,press releases,financial reports,stock quote external,fighting bladder cancer,recent news,close

SERVER

nginx/1.12.2

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home - BioCanCell | biocancell.com Reviews

https://biocancell.com

Gene Therapy for Bladder Cancer. BC-819: Unique Technology, Potent Mechanism. Bladder Cancer: New Solutions Needed. Clinical Features of Bladder Cancer. Clinical Data: A Linear Path to Approval Based on FDA Guidance. BC-821: Next-Generation Recombinant Plasmid. Gene Therapy for Bladder Cancer. BC-819: Unique Technology, Potent Mechanism. Bladder Cancer: New Solutions Needed. Clinical Features of Bladder Cancer. Clinical Data: A Linear Path to Approval Based on FDA Guidance. 2014 Built by BioMarketing.

INTERNAL PAGES

biocancell.com

1

Bladder Cancer - BioCancell

http://www.biocancell.com/lead-program/bladder-cancer

Bladder cancer occurs about 4 times more frequently in men than in women. It is primarily a disease of the elderly population with about 90% of cases occurring in people age 55 or older. The median age of diagnosis is 73 years. Signs and symptoms of bladder cancer include blood in the urine (hematuria) and disturbances in bladder habits. Risk Factors that have been identified for bladder cancer include smoking and work exposure to certain chemicals. Types of Bladder Cancer. BioCancell is a clinical-stage...

2

BC-819 - BioCancell

http://www.biocancell.com/lead-program/bc-819

BC-819 is BioCancell’s leading product, commencing pivotal (Phase III) bladder cancer clinical trials in 2016. BC-819 is a DNA plasmid that does not contain inflammatory or viral elements. It is composed of two regions of interest, the H19 promoter and the Diphtheria Toxin A sequence. BioCancell Advances Intellectual Property Portfolio in the U.S. 8th Euro Global Summit on Cancer Therapy. Info@biocancell.com. 1/3 High-Tech Village, Givat Ram, Jerusalem, Israel. 2014 Built by BioMarketing.

3

BioCancell Files International Patent Request For New Drug Formulation - BioCancell

http://www.biocancell.com/biocancell-files-international-patent-request-for-new-drug-formulation

BioCancell Files International Patent Request For New Drug Formulation. BioCancell Files International Patent Request For New Drug Formulation. May 6, 2015. Jerusalem, Israel — BioCancell Ltd. (TASE:BICL) today announced that it had filed an international patent request under the Patent Cooperation Treaty (PCT), describing a new formulation for its drug BC-819 as a ready-to-use powder. The primary advantages of this formulation are:. BioCancell Advances Intellectual Property Portfolio in the U.S. BioCanc...

4

BioCancell Receives Outline Approval for Two Phase III Bladder Cancer Trials - BioCancell

http://www.biocancell.com/biocancell-receives-outline-approval-for-two-phase-iii-bladder-cancer-trials

BioCancell Receives Outline Approval for Two Phase III Bladder Cancer Trials. BioCancell Receives Outline Approval for Two Phase III Bladder Cancer Trials. October 29, 2014. BioCancell has received approval for two Phase III outlines in patients suffering from bladder cancer – one for patients who failed initial treatment with BCG, the conventional medication for treating bladder cancer (BCG Failures), and the second for patients resistant to treatment of BCG (BCG Refractory). The Israeli Ministry of Hea...

5

Press Releases - BioCancell

http://www.biocancell.com/category/press-releases

BioCancell Advances Intellectual Property Portfolio in the U.S. Biocancell advances phase III clinical program for bladder cancer. Biocancell receives FDA fast track designation for BC-819 for treatment of bladder cancer patients. Biocancell announces development of new diagnostic product BC-830. BioCancell Files International Patent Request For New Drug Formulation. BioCancell Receives Outline Approval for Two Phase III Bladder Cancer Trials. BioCancell Announces Results of Bladder Cancer Trial.

UPGRADE TO PREMIUM TO VIEW 6 MORE

TOTAL PAGES IN THIS WEBSITE

11

LINKS TO THIS WEBSITE

ewinvest.com

Portfolio-EWI Investments

http://www.ewinvest.com/c/default/pageId/57b55a589ccde2430946c9c3

Jerusalem, Israel and Boston, Massachusetts. 1065 West ZhongShan Rd, Suite 1209, Shanghai. Technical support : TUWEIA. Portfolio,EWI Investments,EWI Investments.

antiboycottisrael.blogspot.com

Anti Boycott Israel blog: octobre 2009

http://antiboycottisrael.blogspot.com/2009_10_01_archive.html

Anti Boycott Israel blog. La recherche israélienne sauve des vies et contribue au progrès de la science. Faut-il boycotter Israël? Si oui, mieux vaut être et rester en bonne santé …. Mardi 27 octobre 2009. Cancer de la prostate : un traitement moins agressif vient d'Israël. C'est une troisième voie qui est en train de s'ouvrir pour les hommes atteints de cancer de la prostate. Parmi les cancers dépistés - désormais plus de 70 000 par an en France. Lire l'intégralité de l'article. Lundi 26 octobre 2009.

extracellularbiomarkers.com

Long Non-Coding RNA in Cancer

http://www.extracellularbiomarkers.com/lncRNA

Day 1 Day 2. Tuesday, March 17. 12:00 pm Conference Registration. 1:30 Chairperson’s Opening Remarks. Jingfang Ju, Ph.D., Associate Professor and Co-Director, Translational Research, Pathology, Stony Brook University. 1:35 Non-Coding RNAs in Cancer. Carlo M. Croce, M.D., Distinguished University Professor, The John W. Wolfe Chair in Human Cancer Genetics, Director, Genetics Institute, The Ohio State University. 2:25 Clinical Significance of Long Intergenic Non-Coding RNA-p21 in Colorectal Cancer. Richard...

cbi.co.il

CBI

http://cbi.co.il/biocancell

Frank Haluska, MD, Ph.D.

science.co.il

Israel Biotechnology Companies -

http://science.co.il/Biomedical-Companies.asp

Israel Science and Technology Homepage. Products, Fields of specialty. Directory of agriculture companies. Directory of companies that manufacture medical devices and systems. CLINICAID telemedicine system dispenses personalized drug dosages designated for each specific patient and provides real-time monitoring of clinical trial participants. SlimPack for pharmaceutical packaging of solid oral-dose drugs. Analytical and microbiological tests for the pharmaceutical, cosmetics, food, chemical, biological, ...

UPGRADE TO PREMIUM TO VIEW 7 MORE

TOTAL LINKS TO THIS WEBSITE

12

OTHER SITES

biocanal.ru

Водалайф | Проектирование и монтаж автономных канализаций

Проектирование и монтаж автономных канализаций. Рекомендации по выбору систем автономных канализаций;. Разработка проектной документации и сметы;. Запуск и отладочные работы;. Гарантийное и постгарантийное обслуживание;. Индивидуальные условия при водоснабжении под ключ. Biodeka 5С на 5 человек под ключ. От 89000 т.р. Установка для очистки сточных вод Евробион. От 65 000 руб. Система автономной канализации рассчитана от 3 до 150 жильцов. От 60 700 руб. Автономная канализация Uponor Sako использует.

biocanana.org

Biocañaña Tienda Ecológica - Inicio

Bienvenido a Biocañaña Productos Ecológicos!

biocanapa.com

Biocanapa – Biocanapa

We're not around right now. But you can send us an email and we'll get back to you, asap.

biocanariassolar.com

Venta e Instalación renovables | Los Realejos | Biocanarias Solar

biocanastavirtual.blogspot.com

BioCanasta VIRTUAL

Descubriendo al Perú a través de sus alimentos. Lunes, 30 de agosto de 2010. SEMANA 2: PRODUCTOS BANDERA. Enviar por correo electrónico. Domingo, 22 de agosto de 2010. Enviar por correo electrónico. Sábado, 21 de agosto de 2010. SEMANA 1: ECOSISTEMAS SALUDABLES. SEMANA 1: Del 19 al 26 de agosto. Esta semana comentaremos sobre los ecosistemas saludables y su influencia en los alimentos que produce. Enviar por correo electrónico. Suscribirse a: Entradas (Atom). Mi lista de blogs. LOST CROPS OF THE INCAS.

biocancell.com

Home - BioCanCell

Gene Therapy for Bladder Cancer. BC-819: Unique Technology, Potent Mechanism. Bladder Cancer: New Solutions Needed. Clinical Features of Bladder Cancer. Clinical Data: A Linear Path to Approval Based on FDA Guidance. BC-821: Next-Generation Recombinant Plasmid. Gene Therapy for Bladder Cancer. BC-819: Unique Technology, Potent Mechanism. Bladder Cancer: New Solutions Needed. Clinical Features of Bladder Cancer. Clinical Data: A Linear Path to Approval Based on FDA Guidance. 2014 Built by BioMarketing.

biocancelleria.it

BIOCANCELLERIA, CANCELLERIA BIODEGRADABILI E COMPOSTABILI, BIO CANCELLERIA, biodegradabili, biodegradabile

Giuseppe Brau - cell. (0039)338 2786896 - email quibio@quibio.it. BioCancelleria, Cancelleria Biodegradabile e Compostabile, Bio Cancelleria. E tutti quei prodotti di largo consumo destinati a trovare una collocazione nel mercato, tra gli utenti ecosensibili che preferiscono l' utilizzo di oggetti rispettosi della natura. Il nostro primo obiettivo è la sensibilizzazione all' utilizzo dei prodotti ecocompatibili nel settore dell' usa e getta. Il primo e-commerce Italiano.

biocancer.com

Revista Bio Cancer. Biología y Clínica del Cáncer. Revista Formación Oncología.

Números de la Revista. Acerca de biocáncer.com. Investigación Oncológica en Canarias. Bases genómicas de respuesta oncológica a la irradiación. Principios generales del cáncer. Solicitar una nueva contraseña. Cámaras y Webcam mostrando imágenes en Directo desde México, Argentina, España y resto del mundo. Volumen nº6 - Septiembre 2012 - ISSN 1697-6452. Investigación Oncológica en Canarias. 10 años del ICIC. Volumen nº5 - Diciembre 2011 - ISSN 1697-6452. Volumen nº4 - Enero 2007 - ISSN 1697-6452. Volumen ...

biocancer.com.br

biocancer.com.br - Previna-se de doenças mudando a sua alimentação. Reeduque-se e viva por mais tempo de forma saudável

Previna-se de doenças mudando a sua alimentação. Reeduque-se e viva por mais tempo de forma saudável. It seems we can’t find what you’re looking for. Perhaps searching can help. Proudly powered by WordPress.

biocanconsulting.com

Main

Is a dynamic growing organization pursues this objective in many ways: by helping clients address their toughest challenges, developing ground-breaking knowledge, being entrepreneurs. We aspire to help leaders realize their full potential, while recognizing that every leadership path is unique. Site for updated business news and financial information. It delivers international breaking news, stock. Economic and Political Trends by Countries what you need to know.

biocancroquetas.com

Croquetas BioCan

SOMOS UNA EMPRESA 100% MEXICANA, ADEMAS DE SER FABRICANTES NUESTRO PRECIO ES EL MAS JUSTOS EN MERCADO. ES TIEMPO QUE NOS CONOZCAS. Producto formulado a base de Homeopatía y Nutracéuticos, aditivo orgánico 100% natural e Inocuo, sus componentes de extractos de plantas y homeopatía son aplicadas mediante su fórmula especial, para obtener un mejor desarrollo, y producción. 2014 - BioCan Croquetas - Todos los derechos reservados.